Postoperative infection may influence survival in patients with glioblastoma: Simply a myth?

Neurosurgery

Volumn 69, Issue 4, 2011, Pages 864-868

  De Bonis, Pasquale ^a   Albanese, Alessio ^a   Lofrese, Giorgio ^a   De Waure, Chiara ^a   Mangiola, Annunziato ^a   Pettorini, Benedetta Ludovica ^b   Pompucci, Angelo ^a   Balducci, Mario ^a   Fiorentino, Alba ^a   Lauriola, Libero ^a   Anile, Carmelo ^a   Maira, Giulio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Glioblastoma; Infection; Outcome; Surgical infection; Survival

Indexed keywords

LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ABSCESS; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BONE INFECTION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; ESCHERICHIA COLI INFECTION; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE INFECTION; PRIMARY TUMOR; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RADIOIMMUNOTHERAPY; STAPHYLOCOCCUS INFECTION; SURGICAL WOUND; TREATMENT OUTCOME;

ADULT; AGED; BACTERIAL INFECTIONS; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 80053641609     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318222adfa     Document Type: Article

References (13)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
2. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-566.
3. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997-1003.
4. Bohman LE, Gallardo J, Hankinson TC, et al. The survival impact of postoperative infection in patients with glioblastoma multiforme. Neurosurgery. 2009;64(5):828-834.
5. Miller JT, Rahimi SY, Lee M. History of infection control and its contributions to the development and success of brain tumor operations. Neurosurg Focus. 2005;18(4):e4.
6. Dashti SR, Baharvahdat H, Spetzler RF, et al. Operative intracranial infection following craniotomy. Neurosurg Focus. 2008;24(6):E10.
7. McClelland S III, Hall WA. Postoperative central nervous system infection: Incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis. 2007;45(1):55-59.
8. Bowles AP Jr, Perkins E. Long-term remission of malignant brain tumors after intracranial infection: A report of four cases. Neurosurgery. 1999;44(3):636-643.
9. Kapp JP. Microorganisms as antineoplastic agents in CNS tumors. Arch Neurol. 1983;40(10):637-642.
10. Margolis J, West D. Spontaneous regression of malignant disease: Report of three cases. J Am Geriatr Soc. 1967;15(3):251-253.
11. Naganuma H, Sasaki A, Satoh E, et al. Long-term survival in a young patient with anaplastic glioma. Brain Tumor Pathol. 1997;14(1):71-74.
12. Walker DG, Pamphlett R. Prolonged survival and pulmonary metastases after local cure of glioblastoma multiforme. J Clin Neurosci. 1999;6(1):67-68.
13. Agrawal N, Bettegowda C, Cheong I, et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A. 2004;101(42):15172-15177.